This book presents the current clinical evidence on the efficacy of herbal and nutritional treatments for anxiety that is experienced in association with psychiatric disorder, and explains how health professionals can apply this knowledge to the benefit of patients presenting with a wide range of symptoms, including comorbid mood disorders. All chapters are written by world-leading researchers who draw on the findings of human clinical trials to provide uncompromising assessments of individual treatments, including herbal anxiolytics with sedative actions, adaptogens, cognitive anxiolytics, and nutraceuticals. Traditional treatments requiring further study - including the plant-based psychotropic Ayahuasca and other phytotherapies of potential value in the treatment of anxiety - are also reviewed. In the closing chapters, a series of helpful case studies are provided by mental health clinicians in order to illustrate how herbal and nutritional treatments can best be integrated int
o an overall treatment plan for individuals with a range of comorbid diagnoses. Mental health professionals, researchers, and general readers will find that the book provides an excellent review of current scientific knowledge gained from the study of herbal and nutritional treatments, together with important clinical recommendations for their use in patients experiencing clinically significant levels of anxiety.
Epidemiology of CNS tumors.- Principals of Neurosurgery.- Principals of Radiation Oncology.- Neuroimaging for CNS tumors.- CNS tumor predisposition syndromes.- Modern principals of CNS Tumor Classification.- Medulloblastoma.- Ependymoma.- High Grade Glioma.- Diffuse Pontine Glioma.- Low Grade Glioma.- CNS Germ Cell Tumors.- Craniopharyngioma.- Rare CNS Tumors.- Infant tumors.- Late effects - Neurocognitive outcomes.- Late Effects - Endocrine deficiencies; Second Malignancies; Late Mortality.- Global Challenges in Neuro Oncology.- Future Directions.
Recenzijos
Brain Tumors in Children would be an excellent resource for residents and fellows with an interest in pediatric neurosurgery or neuro-oncology or for allied health providers seeking a broad background in pediatric brain tumors. More senior practitioners whose routine practice is not oncological may find this a useful reference as well. (Karl Balsara, Neurosurgery, Vol. 85 (2), August, 2019)
Epidemiology of CNS tumors.- Principals of Neurosurgery.- Principals of
Radiation Oncology.- Neuroimaging for CNS tumors.- CNS tumor predisposition
syndromes.- Modern principals of CNS Tumor Classification.- Medulloblastoma.-
Ependymoma.- High Grade Glioma.- Diffuse Pontine Glioma.- Low Grade Glioma.-
CNS Germ Cell Tumors.- Craniopharyngioma.- Rare CNS Tumors.- Infant tumors.-
Late effects Neurocognitive outcomes.- Late Effects Endocrine
deficiencies; Second Malignancies; Late Mortality.- Global Challenges in
Neuro Oncology.- Future Directions.
Amar Gajjar, M.D., is Chair of the Department of Pediatric Medicine at St. Jude Childrens Research Hospital, Memphis, TN, USA. He has a long history at St. Jude, having undertaken a Pediatric Hematology/Oncology Fellowship there from 1989 to 1992 and then an additional year of Fellowship in Pediatric Neuro-Oncology. Since joining the Division of Neuro-Oncology as a Faculty Member in 1993, he has risen steadily through the academic ranks. He was appointed Division Director of Neuro-Oncology in 2002 and promoted to Full Member (Professor) in 2004. In 2005, he was appointed Co-Leader of the Neurobiology and Brain Tumor Program. In recognition of his academic excellence, in 2007 he was awarded the Scott and Tracie Hamilton Endowed Chair in Brain Tumor Research. He took up his present position in 2016. Nationally, Dr. Gajjar has served as the Chair of the Brain Tumor Committee in the Childrens Oncology Group (200917). Dr. Gajjar is principal or co-principal investigator in several innovative clinical trials of new treatments for a variety of brain tumors. He serves on the editorial boards of Neuro-Oncology and UpToDate and is a past editorial board member of the Journal of Clinical Oncology. Dr Gajjar has contributed significantly to the literature and has published work in various high impact journals.
Gregory H. Reaman, M.D. joined the Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration as the Associate Director of the Office of Oncology Drug Products in 2011. He is the Founding and Immediate Past Chair of the Childrens Oncology Group (COG) having served in this capacity from 2000 through 2010. The COG is comprised of over 200 member institutions, dedicated to clinical, translational, and epidemiology research in childhood cancer. He is a Professor of Pediatrics at The George Washington University School of Medicine and Health Sciences and a member of theDivision of Hematology-Oncology at the Childrens National Medical Center in Washington, D.C., which he directed for more than 17 years. He has served on the Editorial Boards of Leukemia, Journal of Clinical Oncology, Journal of Pediatric Hematology/Oncology, Pediatric Blood and Cancer, The Oncologist, Cancer, and Physicians Data Query (PDQ), National Cancer Institute as well as www.PLWC.org (People Living with Cancer, now Cancer.net). He has served as an Associate Editor of Cancer and Leukemia and Lymphoma. He served on the Board of Directors of the American Cancer Society and chaired its Task Force on Children and Cancer. He has authored or co-authored more than 300 peer-reviewed publications and more than 25 books and book chapters. His research interests include the biology and therapy of childhood acute leukemia and new drug development for pediatric cancer.
Judy M. Racadio is a former Emergency Medicine physician who currently performs medical writing and editing for various academic medical, private medical, and corporate departments. She received her M.D. in 1992 from the University of Cincinnati. After completing her Emergency Medicine residency, she spent 6 years as an Assistant Professor of Emergency Medicine at the University of Cincinnati. Since leaving clinical medicine, she has provided editorial assistance for textbooks on pediatric leukemia, pediatric hematopoetic cell transplant and pediatric radiology. She has also written a series of continuing education modules for radiology technologists and has co-authored or provided editorial assistance for more than 60 peer-reviewed publications and book chapters. She is currently an Associate Editor for the Emergency Medicine Cardiac Research and Education Group (EMCREG).
Franklin O. Smith, III, M.D., FAAP, FACP, is Vice President for Medical Affairs at Medpace and is Professor of Medicine and Pediatrics at the University of Cincinnati Collegeof Medicine. He graduated from the University of South Carolina School of Medicine and completed postdoctoral training in pediatrics at the University of Florida and fellowship training in pediatric hematology/oncology at the University of Washington and the Fred Hutchinson Cancer Research Center. Prior to joining Medpace, Dr. Smith was the Clinical Director at the University of Cincinnati Cancer Institute. Previously, he was the Director, Division of Hematology/Oncology at Cincinnati Children's Hospital Medical Center and Vice-Chair of the Children's Oncology Group. He has authored more than 170 articles in medical and scientific journals. Dr. Smith is active with various national and international committees and societies in the field of research and clinical care. He serves on National Board of Directors for the Leukemia and Lymphoma Society, President of the Board of Managers for FACT Consulting Services, faculty for the ASCO/AACR Clinical Cancer Research Workshop, and a member ofthe NCI's Central Institutional Review Board. Dr. Smith has also served on standing and ad hoc committees for the FDA and NIH.
Daugiau apie elektronines knygas